Natco Pharma Share Price Gains Over 2%; Announces Board Meeting for Agrochemicals Division Demerger

Natco Pharma Limited has announced a board meeting set for March 24, 2026. The primary agenda is to consider the demerger of its Agrochemicals Division. This division will be transferred to its wholly owned subsidiary, Natco Crop Health Sciences Limited, on a going concern basis. 

Details of the Board Meeting 

The board meeting is scheduled for March 24, 2026. The key focus will be on the Scheme of Arrangement for the demerger of the Agrochemicals Division. This strategic move aims to streamline operations by transferring the division into Natco Crop Health Sciences Limited. 

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in Natco Pharma's securities will be closed from March 19, 2026, to March 26, 2026. This applies to employees, connected persons, and their immediate relatives. 

Trading Window Closure 

The trading window closure is a standard procedure to prevent insider trading during significant corporate events. It ensures that no unfair advantage is taken by those with access to sensitive information. The trading window will reopen on March 27, 2026. 

Impact on Natco Pharma and Subsidiary 

The demerger is expected to allow Natco Pharma to focus more on its core pharmaceutical operations while enabling Natco Crop Health Sciences Limited to specialise in agrochemical products. This separation could enhance operational efficiency and market focus for both entities. 

Read More: Biopharma SHAKTI Scheme: Strengthening India’s Biologics and Biosimilars Ecosystem! 

Natco Pharma Share Price Performance 

As of March 20, 2026, at 12:09 PM, Natco Pharma share price on NSE was trading at ₹959.15 up by 2.25% from the previous closing price. 

Conclusion 

Natco Pharma's decision to hold a board meeting on March 24, 2026, to discuss the demerger of its Agrochemicals Division marks a significant step in its corporate strategy. The move to transfer this division to Natco Crop Health Sciences Limited is aimed at enhancing operational focus and efficiency. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.